Bechter R, Terlouw G D, Tsuchiya M, Tsuchiya T, Kistler A
Drug Safety Assessment, Sandoz Pharma Ltd, Basel, Switzerland.
Arch Toxicol. 1992;66(3):193-7. doi: 10.1007/BF01974014.
Structural modifications of the arotinoid molecule RO 13-7410 led to a difference in the teratogenic potencies of more than five orders of magnitude in mice in vivo and in micromass cultures of rat embryonic limb bud cells (Kistler et al. 1990). Five of these retinoids were selected and tested in rat whole embryo culture to determine the suitability of this in vitro test system for the identification of potentially non-teratogenic derivatives among this class of chemicals. The highest concentrations of the compounds with no effects (NOAEL) on general conceptus growth, on differentiation and on the frequency of dysmorphogenic embryos in vitro were compared with the lowest effective teratogenic doses in vivo (LOAEL) or with the concentrations leading to 50% inhibition of limb bud cell differentiation (IC50) in vitro. NOAEL's for the parameters of conceptus development ranged from 10(-5) micrograms/ml (0.03 nM) to 10 micrograms/ml (28.7 microM) for the compounds tested. These correlated very well with LOAEL and IC50 (R greater than 0.95). The types of dysmorphogenesis in vitro were those typical for retinoids, and for the most part resembled the malformations found in vivo. We conclude that the whole embryo culture system is a useful tool for the preliminary testing of retinoids.
芳维A酸分子RO 13-7410的结构修饰导致其致畸效力在小鼠体内以及大鼠胚胎肢芽细胞的微团培养中相差超过五个数量级(基斯特勒等人,1990年)。从这些维甲酸中选取了五种,并在大鼠全胚胎培养中进行测试,以确定这种体外测试系统对于识别这类化学物质中潜在非致畸衍生物的适用性。将对体外胚胎总体生长、分化以及畸形胚胎频率无影响的化合物最高浓度(无观察到不良反应水平,NOAEL)与体内最低有效致畸剂量(最低观察到有害作用水平,LOAEL)或导致体外肢芽细胞分化50%抑制的浓度(半数抑制浓度,IC50)进行比较。所测试化合物在胚胎发育参数方面的NOAEL范围为10^(-5)微克/毫升(0.03纳摩尔)至10微克/毫升(28.7微摩尔)。这些与LOAEL和IC50相关性非常好(R大于0.95)。体外畸形发生的类型是维甲酸典型的类型,并且在很大程度上类似于体内发现的畸形。我们得出结论,全胚胎培养系统是维甲酸初步测试的有用工具。